Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

Clinical trial NCT00724984 · COMPLETED

Trial details

NCT number: NCT00724984
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Hodgkin Disease Lymphoma, Non-Hodgkin

Start date: 2008-07-01
Primary completion: 2012-11-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.